EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Scaling human liver microphysiological systems: implementing a higher-throughput liver acinus microphysiological system platform

Dillon C Gavlock, Michael W Castiglione, Allen Wang, Mahboubeh Varmazyad, Lawrence A Vernetti, Mark E Schurdak, D Lansing Taylor, Jacquelyn A Brown, Mark T Miedel

Experimental Biology and Medicine · 22.05.2026 · 251

DOI: 10.3389/ebm.2026.11038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Biology and Medicine, online erschienen am 22.05.2026. Verfasst von Dillon C Gavlock und 8 weiteren Autor:innen. Beteiligte Einrichtung: Organ Pathobiology and Therapeutic Institute, University of Pittsburgh, Pittsburgh, PA, United States. Hauptthemen laut MEDLINE: Microphysiological Systems, Liver, High-Throughput Screening Assays. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The advancement in the use of all-human high content microphysiological systems (MPS) has enabled better in vitro modeling of liver function and disease progression as well as drug efficacy, metabolism and toxicity (ADME-Tox) testing. However, a continuing need in liver MPS development is balancing throughput without loss of the high-content biological complexity required for physiologically relevant modeling. Here, we present a scalable version of our well-established liver acinus microphysiological system (LAMPS). This higher-throughput format (ht-LAMPS) is designed to recapitulate the physiological complexity of the standard single-chamber LAMPS system while increasing experimental capacity through a seven-chamber microfluidic design. The ht-LAMPS is constructed using the same four key liver cell types as the LAMPS: primary hepatocytes and liver sinusoidal endothelial cells (LSECs) as well as Kupffer-like cells (THP-1) and hepatic stellate cells (LX-2). It recapitulates key physiological characteristics previously established in the LAMPS platform, including oxygen zonation–dependent liver phenotypes including model viability, secretion of functional and cytotoxicity markers, mitochondrial activity, and lipid accumulation, demonstrating reproducibility in the ht-LAMPS format. Finally, we also demonstrate that the ht-LAMPS model recapitulates key phenotypes associated with the progression of metabolic dysfunction–associated steatotic liver disease (MASLD), including increased steatosis and elevated production of inflammatory cytokines and profibrotic markers using our established MASLD media formulations. Overall, by increasing throughput while maintaining key high-content biological features of the LAMPS, ht-LAMPS provides a scalable platform for investigating liver function, modeling disease progression, and enabling downstream drug testing in MASLD and other liver-related conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Microphysiological SystemsLiverHigh-Throughput Screening AssaysHumansHepatocytesHepatic Stellate CellsKupffer CellsEndothelial Cells

Stichwörter der Autor:innen

in vitro liver modelliver-on-a-chipmetabolic dysfunction–associated steatotic liver diseasemicrophysiological systemsnew approach methodologies

Autor:innen und Institutionen

  • Organ Pathobiology and Therapeutic Institute, University of Pittsburgh, Pittsburgh, PA, United States.
  • Department of Computational and System Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
  • Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA, United States.
  • Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, United States.

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health

Zitieren

APA

Gavlock, D. C., Castiglione, M. W., Wang, A., Varmazyad, M., Vernetti, L. A., Schurdak, M. E., Taylor, D. L., Brown, J. A., & Miedel, M. T. (2026). Scaling human liver microphysiological systems: implementing a higher-throughput liver acinus microphysiological system platform. Experimental Biology and Medicine, 251. https://doi.org/10.3389/ebm.2026.11038

Vancouver

Gavlock DC, Castiglione MW, Wang A, Varmazyad M, Vernetti LA, Schurdak ME, et al. Scaling human liver microphysiological systems: implementing a higher-throughput liver acinus microphysiological system platform. Experimental Biology and Medicine. 2026;251. doi:10.3389/ebm.2026.11038

BibTeX
@article{Gavlock2026,
  author = {Gavlock, Dillon C and Castiglione, Michael W and Wang, Allen and Varmazyad, Mahboubeh and Vernetti, Lawrence A and Schurdak, Mark E and Taylor, D Lansing and Brown, Jacquelyn A and Miedel, Mark T},
  title = {Scaling human liver microphysiological systems: implementing a higher-throughput liver acinus microphysiological system platform},
  journal = {Experimental Biology and Medicine},
  year = {2026},
  volume = {251},
  doi = {10.3389/ebm.2026.11038}
}
Kostenlos starten →